Better treatment selection and improved therapies -- key to improving prognosis in acute HF
...de), peripheral vasodilators (nitrates) and inotropic agents. Even the more recently approved treatments, he added, such as levosimendan in Europe and nesiritide
in the USA, have been associated with uncertain effects on outcomes in randomised trials. "So hospitalisations for acute heart failure are still assoc...
Study Supports Controversial Heart Failure Drug
...r other care, over the following 30 days.
"The main findings were that nesiritide
did not cause renal [kidney] dysfunction in high-risk patents who were hosp...particular context as well as in a particular fashion. I still believe that nesiritide
is a very useful drug in the appropriate person."
That explanation doesn...
Nesiritide in Medical Technology
Scios Announces Results From Exploratory Nesiritide Study Providing
Important New Renal and Mortality Safety Data with a Neutral Effect
on the Primary Endpoint
-- Data from Serial Outpatient Infusion Study in Patients with
Chronic Decompensated Heart Failure Presented at the American
College of Cardiology 56th Annual Scientific Session --
MOUNTAIN VIEW, Calif. and NEW ORLEANS, March 25, 2007
/PRNewswire/ -- Scios Inc. announced today that an exploratory,...
Everest Data on Short- and Long-Term Use of Otsuka's
Investigational Novel Treatment, Tolvaptan, Published in Journal of
the American Medical Association and Featured in ACC's Late
Breaking Clinical Trials
...ies for their patients, including diuretics, digoxin, ACE
inhibitors, angiotensin II receptor blockers, aldosterone blockers,
beta-blockers, nitrates, nesiritide
"EVEREST adds to the collection of data on tolvaptan and its
potential uses," said Kazumichi Kobayashi, Chairman & CEO of...